Schnieders Capital Management LLC Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Schnieders Capital Management LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,931 shares of the healthcare conglomerate’s stock after selling 962 shares during the quarter. UnitedHealth Group accounts for 2.0% of Schnieders Capital Management LLC’s investment portfolio, making the stock its 12th biggest position. Schnieders Capital Management LLC’s holdings in UnitedHealth Group were worth $8,914,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Wellington Management Group LLP grew its holdings in shares of UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after purchasing an additional 527,526 shares during the last quarter. Northern Trust Corp grew its holdings in UnitedHealth Group by 3.6% in the 3rd quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after acquiring an additional 341,749 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in UnitedHealth Group by 2.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after acquiring an additional 180,331 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in UnitedHealth Group by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after acquiring an additional 27,127 shares during the last quarter. Finally, Sanders Capital LLC boosted its stake in shares of UnitedHealth Group by 6.5% during the 3rd quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock valued at $2,902,829,000 after purchasing an additional 352,710 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Down 1.0 %

UnitedHealth Group stock traded down $4.86 during trading hours on Tuesday, hitting $486.37. The stock had a trading volume of 3,645,655 shares, compared to its average volume of 4,543,351. The stock has a market capitalization of $448.40 billion, a P/E ratio of 29.73, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54. The stock’s 50-day moving average price is $487.49 and its 200-day moving average price is $514.76. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.26 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on UNH. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Morgan Stanley cut their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Barclays lifted their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Bank of America reissued a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Finally, StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.